Commission halts TB drug investigation as intervention leads to 40% price decrease

News Competition Sanctions & Fines

Date: 5th Jul, 2024 Source: Competition Commission Country: South Africa Original Source

Brief

"On 05/07/2024, the Competition Commission issued an update regarding Commission halts TB drug investigation as intervention leads to 40% price decrease. The Commission decided not to prosecute Johnson & Johnson and Janssen Pharmaceutica for alleged anti-competitive conduct related to Bedaquiline patent restrictions, allowing generic suppliers entry into 134 low- and middle-income countries, including South Africa, with a resulting 40% price reduction."

This content is restricted.

Highlights content goes here...

This content is restricted.

Competition Commission

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Commission halts TB drug investigation as intervention leads to 40% price decrease

Brief

Competition Commission

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Commission halts TB drug investigation as intervention leads to 40% price decrease

Brief

Competition Commission

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.